Inogen completed the sale of its U.S. oxygen rental business to Rotech Healthcare Inc. on November 2, 2026, for estimated cash consideration of up to $24.8 million payable in six installments. Concurrently, the Board appointed COO Andy Reding as President and CEO, succeeding Kevin Smith. The company also initiated a cost reduction program expected to generate approximately $20 million in annualized savings by the end of 2027. Inogen reported third-quarter revenue from continuing operations of $77.2 million and increased its share repurchase authorization by $15 million to $45 million. Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting.
